Aro Biotherapeutics logo

Aro Biotherapeutics

0 followers

Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.

Industries

Employees

11-50

Links


Org chart

Susan Dillon
Board Chair
Collapse
Zhanna Druzina
Executive Director
Melissa Brookes
Vice President Clinical Operations
Mark Laurenzi
Chief Administrative Officer & VP, Legal
Steve Liapis
Board Member

Board & advisors

Liz Mckee Anderson
Independent Board Director, Chair Compensation Committee, Member, Audit Committee
Bruce Peacock
Independent Director
Christopher Mirabelli
Independent Director
Kevin Raidy
Director
Martin McMahon
Scientific Advisor
Ron Swanson
Scientific Advisory Board
Phillip S. Low
Scientific Advisor
Matthew Gentry
Scientific Advisor